Loading
AD
ACGT DNA Technologies Corporation Stock: price and insider trades · Canada
ACGT DNA Technologies Corporation: what insiders have been doing
Only a handful of insider records exist for ACGT DNA Technologies Corporation, the last one from 25 June 2019, too few to describe a trend. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 25 June 2019
Declarations7 total
150,000 shares@ CA$0.50100.0% of flowCommon SharesTSXSEDI:3388092
Common SharesTSXSEDI:3388085
Common SharesTSXSEDI:3240328
100,000 sharesCommon SharesTSXSEDI:3240333
Canonical exit: 20 Dec 2018 (T+90)
Common SharesTSXSEDI:3151836
Common SharesTSXSEDI:3130847
Common SharesTSXSEDI:3130692
7 of 7 declarations
About ACGT DNA Technologies Corporation
ACGT DNA Technologies Corporation is a company specializing in DNA technologies, providing innovative solutions for genomic research. It is listed on the XTSE.
